# TB-CAPT MTB/XDR Study

> **NCT04567368** · — · ACTIVE_NOT_RECRUITING · sponsor: **Foundation for Innovative New Diagnostics, Switzerland** · enrollment: 753 (actual)

## Conditions studied

- Tuberculosis
- Resistance Bacterial
- Diagnoses Disease

## Interventions

- **DIAGNOSTIC_TEST:** Xpert MTB/XDR

## Key facts

- **NCT ID:** NCT04567368
- **Lead sponsor:** Foundation for Innovative New Diagnostics, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-05-14
- **Primary completion:** 2024-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 753 (ACTUAL)
- **Last updated:** 2024-10-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04567368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04567368, "TB-CAPT MTB/XDR Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04567368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*